Writing the Future of Drug of Discovery and Development

Presented by

Emily Leproust

Twist Bioscience

Technological advances over the past five decades have improved our ability to identify and optimize drug candidates for pre-clinical and clinical testing. New approaches, modalities and companies are expanding the druggable space, and formerly “hard-to-drug” targets are moving within reach of drug developers.

Share your details to Watch the Webinar

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Writing the Future of Drug of Discovery and Development

Related Resources

HT-SPR Technology to Inform and Accelerate the Antibody Discovery Process

Accelerate GPCR Antibody Discovery with Synthetic DNA Technologies

Hyperimmune scFv Library: Pure Biologics and Twist Bioscience Partnering